Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Alberta

$438,708.00

Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis

EF 2011-12

Résumé
This proposal stems from our recent observations that muscle wasting is common in people with cancer. Often, muscle loss associates with increased content of fat in muscle. Each of these features is related to morbidity and survival in people with cancer. Here, we propose new basic research to understand the biological causes of muscle wasting, as well as propose an intervention to modify muscle loss and fat in muscle. Two questions will be explored. The first of these relates to the reasons for muscle loss and replacement of the muscle tissue by fat tissue. This may be due to alterations in the muscle cells responsible for regeneration and renewal of muscle, or changes in the signals that govern muscle cell or fat cell growth. The second question relates to the ability of a nutritional intervention containing fats thought to be important for muscle health to reduce the loss of muscle and fat within the muscle tissue. Reasons for the benefits will be explored.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
239577
Name
Mazurak Vera C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$438,708
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Adipogenesis; Essential Fatty Acids; Lipid Metabolism; Muscle Health; Myosteatosis; Nutrient Requirements; Satellite Cells
Abstract
This proposal stems from our recent observations that muscle wasting is common in people with cancer. Often, muscle loss associates with increased content of fat in muscle. Each of these features is related to morbidity and survival in people with cancer. Here, we propose new basic research to understand the biological causes of muscle wasting, as well as propose an intervention to modify muscle loss and fat in muscle. Two questions will be explored. The first of these relates to the reasons for muscle loss and replacement of the muscle tissue by fat tissue. This may be due to alterations in the muscle cells responsible for regeneration and renewal of muscle, or changes in the signals that govern muscle cell or fat cell growth. The second question relates to the ability of a nutritional intervention containing fats thought to be important for muscle health to reduce the loss of muscle and fat within the muscle tissue. Reasons for the benefits will be explored.
Competitiondate
201109
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mazurak, Vera C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $438,708~ $0~